ML-7

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameML-7
Drug Alias NameMLCK Inhibitor (Neuroptis Biotech)Myosin Light Chain Kinase Inhibitor (Neuroptis Biotech)NOP-4ML-7
ClassificationSmall molecules
Mechanisms of ActionMyosin light chain kinase, smooth muscle inhibitors
TargetsMyosin light chain kinase, smooth muscle
Therapy Area/IndicationsMacular DegenerationXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeuroptis Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuroptis Biotech
Active IndicationsN/A
Inactive IndicationsMacular DegenerationXerophthalmia

Other Information

ATC CodeN/A
Related LinksN/A